Interventions Against Sarcopenia in Older Persons

ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)

Volume 22, 46 Issues, 2016

Download PDF Flyer

Current Pharmaceutical Design

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 62nd of 254 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

William A. Banks
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.452
5 - Year: 3.504

Interventions Against Sarcopenia in Older Persons

Current Pharmaceutical Design, 20(38): 5983-6006.

Author(s): Zanandrea Valeria, Giua Renato, Costanzo Luisa, Vellas Bruno, Zamboni Mauro and Cesari Matteo.

Affiliation: Institut du Vieillissement, Universite Toulouse III – Paul Sabatier, 37 Allees Jules Guesde, 31000 Toulouse France.


The term "sarcopenia" describes the age-related loss of skeletal muscle mass and function. It represents a major risk factor for functional loss and disability in older persons. Multiple underlying pathophysiological mechanisms have been posed at the basis of the sarcopenia phenomenon, including intrinsic (e.g., age-related modifications of the skeletal muscle, the central nervous system, and hormones) and extrinsic (e.g., sedentariness, poor protein dietary intake) factors.

Several interventions have been explored in the last years to counteract the age-related muscle decline. These include protein supplementations, physical exercise, testosterone replacement (as well as other anabolic androgens) in men, estrogen replacement in women, growth hormone replacement, and treatment of vitamin D deficiency. To date, adequate protein intake and resistance training are the most promising interventions able to prevent and/or delay the decline of muscle mass and function.

An intense debate is currently ongoing about the best operational definition able to capture the complexity of this aging condition. In the context of identifying the optimal treatment for a specific condition, this is not a trivial issue because it sets the target of the intervention as well as the population at risk. Nevertheless, despite the current methodological issues, it is important to preliminarily test the possible strategies that might be implemented in the future, when the sarcopenia condition will finally be more univocally defined and its clinical relevance recognized.

Aim of the present review is to describe and discuss available evidence about the possible interventions potentially serving at acting against sarcopenia. Pharmacological as well as non-pharmacological interventions are presented.


Elderly, disability, physical function, prevention, sarcopenia, skeletal muscle, treatment.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 20
Issue Number: 38
First Page: 5983
Last Page: 6006
Page Count: 24
DOI: 10.2174/1381612820666140316132246

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science